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LETTERS TO THE EDITORRegarding “Altered fibrin clot structure and function
in individuals with intermittent claudication”
We recently demonstrated that healthy first-degree relatives of
individuals with intermittent claudication formed ex-vivo fibrin
clots that are less porous, have significantly thicker fibers, increased
factor XIII crosslinking, and are more resistant to fibrinolysis
compared with a control group.1 This study suggested a mecha-
nism through which a positive family history may produce delete-
rious effects and may have implications in the future cardiovascular
risk of what is apparently a healthy subgroup of the population.1
Previous studies demonstrated abnormal fibrin clot structure in
individuals with myocardial infarction2 and diabetes mellitus.3 Young
postinfarct patients produced clots with a tighter, less porous rigid
structure,2 and diabetic patients also formed a thin-fiber, low-porosity
clot network.3 Fatah et al2 declared that the tight, rigid fibrin gel
networks might be important for the formation and progression of
coronary lesions. Furthermore, they suggested that clot resiliency, or
resistance to lysis, could also affect plaque growth and the formation
of hemodynamically significant stenoses.2 It was therefore expected
that claudicant patients would form clots that were significantly dif-
ferent compared with a control group. In addition, fibrin clot struc-
ture has not been previously studied in claudicant patients.
We performed assays for clot permeation, fiber thickness by
turbidity and laser scanning confocal microscopy, factor XIII
crosslinking, and fibrinolysis, as described previously.1 Assays were
performed on 34 individuals who represented a relatively young
group of patients with mild to moderate peripheral arterial disease
(PAD) whose intervention rate and concomitant generalized ath-
erosclerotic disease was comparable with the PAD population as a
whole. Assays were only performed on this number due to financial
and time constraints. In addition, there were potentially confound-
ing factors because participants had established clinically significant
disease and were receiving cardiovascular medications, which are
known to affect clot structure.3-5 These medications have been
shown to have a beneficial effect on clot structure and so would not
introduce a positive bias. In addition, because the group of first-
degree relatives mainly consisted of sons, the intermittent claudi-
cation study group was significantly older than the other groups.1
The claudicant patients have the least permeable, most rigid
clots, which are made up of the thickest fibers and are most
resistant to fibrinolysis, compared with the other groups (Table).
This novel work has characterized an abnormal fibrin clot struc-
ture in claudicant patients and supports the work of others indicating
abnormal clot structures in individuals with atherothrombotic dis-
ease.2,3 The literature clearly shows that intermittent claudication is
independently associated with up to a sixfold increase in risk of
Table. Fibrin clot structure and function data
Clot variable Control FD
Ks 109 cm2a 15.6 (14.7-16.6) 14.6 (13
MAb 0.75 (0.67-0.93) 0.86 (0.
F XIII activity, %b 105 (87-141) 133 (10
Fiber thickness on LSCM,a nm 315.8 (307.0-324.6) 405.1 (39
Lysis front velocity,a m/min 12.66 (6.38-18.94) 4.83 (2.
FDR, First-degree relative; Ks, average pore size; LSCM, laser scanning con
aParametric data are expressed as the mean (95% confidence interval).
bNonparametric data are expressed as median (IQR).
1088cardiovascularmortality comparedwith the healthy population.6 This
abnormal clot structure may also explain an aspect of the develop-
ment, clinical manifestation, and progression of PAD, along with the
increased frequency of cardiovascular events in these patients.
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Regarding “Strategies to improve spinal cord ischemia
in endovascular thoracic aortic repair: Outcomes of a
prospective cerebrospinal fluid drainage protocol”
We read with interest the recent article by Hnath et al1 on
outcomes after routine cerebrospinal fluid (CSF) drainage to pre-
vent spinal cord ischemia (SCI) in patients undergoing thoracic
endovascular aneurysm repair (TEVAR).
We routinely use CSF drainage and maintain a high mean
arterial pressure to prevent SCI in all patients having open thora-
coabdominal aneurysm repair. We performTEVAR under epidural
anesthesia, which provides a good sensory block but preserves
motor function, allowing assessment of spinal cord function intra-
operatively and postoperatively. We do not, therefore, use prophy-
lactic CSF drainage. We have found emergency CSF drainage with
elevation of mean arterial pressure can reverse symptoms if SCI
develops after endovascular aneurysm repair.2 Of 260 cases in our
center, SCI developed in 10 patients (3.8%) and was reversed by
CSF drainage in 7. We agree that the risk of SCI is higher in
patients who have had a previous abdominal aortic aneurysm
repair, patients in whom a long length of the thoracic aorta will be
covered, and in procedures that require coverage of the left sub-
clavian artery without revascularization.
It should be pointed out, however, that CSF drainage is not
without its complications. We have had three major complications
to date from CSF drains placed for patients having both open
repair and TEVAR. One patient developed a temperature and had
raised inflammatory markers 48 hours after insertion of the CSF
drain. A magnetic resonance imaging scan showed an epidural
abscess at the site of drain placement (Fig, A). This resolved after
antibiotic treatment, but the patient has residual paraparesis, with
lower limb weakness and urinary incontinence. Two other patients
were found to have retained CSF drains on routine follow-up scans
where a residual portion of the catheter had broken off inside the
spinal canal (Fig, B and C). They are currently symptomless,
Fig. A, Patient 1: Magnetic resonance scan shows col
Retained catheter (arrow) found on routine follow-up
found on routine follow-up computed tomography scan.however, and after consultation with neurologists and neurosur-
geons, no further treatment is planned.
Subdural hematomas have been reported as a direct result of
lumbar spinal drainage.3,4 Settepani et al5 also reported intracerebellar
hematomata in two patients after drainage of large volumes of CSF.
Complications secondary to spinal drains are relatively rare, and in
high-risk patients and open thoracoabdominal aneurysm repair, pro-
phylactic CSF drainage should be considered. This may be an unnec-
essary risk, however, in patients having TEVAR who have not had
previous abdominal aneurysm repair and in whom the subclavian
artery is not being covered or those who have had prior subclavian
artery revascularization. We, therefore, agree that mandatory CSF
drainage for all patients undergoing TEVAR is unnecessary.
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